Why Tandem Diabetes Care Stock Thrashed the Market Today
Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...
TNDM Stock Likely to Gain From Innovation Amid Competition
Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...
drugdeliverybusiness4d
Tandem wins clearance for t:slim X2 pump with Eli Lilly fast-acting insulin in Europe
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...
Medscape6d
Guidance Will Aid Pediatric to Adult Diabetes Care Transfer
Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...
kalkinemedia4d
Tandem Diabetes Gains Momentum with Key EU Approval
Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...
The Globe and Mail5d
Why Tandem Diabetes Care Stock Thrashed the Market Today
Tandem Diabetes Care(NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit the headlines investors piled into the stock. At the end of the day the ...
Stockhouse5d
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) ...
The Lancet4d
The promise of once-weekly insulins for type 1 diabetes: update on progress
For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...